Orbimed Advisors LLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $2.8 Billion distributed in 103 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Boston Scientific Corp with a value of $302M, Eli Lilly & CO with a value of $263M, Edgewise Therapeutics, Inc. with a value of $203M, Intuitive Surgical Inc with a value of $158M, and Stryker Corp with a value of $142M.

Examining the 13F form we can see an decrease of $407M in the current position value, from $3.21B to 2.8B.

Orbimed Advisors LLC is based out at San Diego, CA

Below you can find more details about Orbimed Advisors LLC portfolio as well as his latest detailed transactions.

Portfolio value $2.8 Billion
Healthcare: $2.8 Billion

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 103
  • Current Value $2.8 Billion
  • Prior Value $3.21 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 14 stocks
  • Additional Purchases 19 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 23 stocks
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.